|
Market Closed -
Other stock markets
|
Pre-market 07:02:25 pm | |||
| 136.30 USD | +3.49% |
|
140.25 | +2.90% |
| Jul. 16 | Kalshi to allow bets on clinical trials, FDA decisions | RE |
| Jul. 15 | African markets - factors to watch on July 15 | RE |
| Market Cap | 164B 143B 132B 121B 230B 15,752B 234B 1,576B 618B 7,683B 614B 601B 26,540B | P/E 2026 * |
-49.1x | P/E 2027 * | 17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 173B 151B 140B 128B 243B 16,664B 247B 1,667B 654B 8,127B 649B 635B 28,076B | EV / Sales 2026 * |
5.68x | EV / Sales 2027 * | 5.05x |
| Free-Float |
99.88% | Yield 2026 * |
2.38% | Yield 2027 * | 2.47% |
Last Transcript: Gilead Sciences, Inc.
| 1 day | +3.49% | ||
| 1 week | +0.35% | ||
| Current month | +7.88% | ||
| 1 month | +9.65% | ||
| 3 months | -2.48% | ||
| 6 months | +12.40% | ||
| Current year | +11.05% |
| 1 week | 127.94 |  | 136.44 |
| 1 month | 122.43 | | 137.7 |
| Current year | 116.88 | | 157.29 |
| 1 year | 107.75 | | 157.29 |
| 3 years | 62.07 | | 157.29 |
| 5 years | 57.16 | | 157.29 |
| 10 years | 56.56 | | 157.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 2019-02-28 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 2019-10-31 |
Keeley Wettan
CMP | Compliance Officer | - | 2025-12-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 2016-08-18 |
| Director/Board Member | 73 | 2017-12-31 | |
Harish Manwani
BRD | Director/Board Member | 72 | 2018-05-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/1/26 | Sell | Chief Executive Officer | -15,000 | 0.0012% | ||
| 6/15/26 | Sell | Executive/Senior Manager | -3,000 | 0.0002% | ||
| 6/15/26 | Sell | Chief Financial Officer | -3,000 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.49% | +0.35% | +24.98% | +76.58% | 164B | |
| +1.08% | -3.84% | +51.50% | +160.13% | 1,031B | |
| +1.19% | -5.10% | +61.09% | +56.36% | 595B | |
| +4.21% | +0.65% | +36.48% | +87.04% | 431B | |
| +0.42% | -0.99% | +30.04% | +22.27% | 326B | |
| +1.03% | -2.10% | +28.32% | +45.08% | 277B | |
| +0.49% | -11.32% | +20.31% | +22.32% | 263B | |
| +1.59% | +3.91% | -22.47% | -36.84% | 224B | |
| +3.70% | +0.98% | +27.03% | +63.38% | 193B | |
| +1.29% | +4.53% | +2.15% | -30.78% | 141B | |
| Average | +1.52% | -3.09% | +25.94% | +46.55% | 364.58B | |
| Weighted average by Cap. | +1.18% | -4.02% | +36.41% | +75.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.47B 26.62B 24.63B 22.61B 42.77B 2,935B 43.54B 294B 115B 1,432B 114B 112B 4,945B | 32.4B 28.31B 26.19B 24.04B 45.48B 3,121B 46.3B 312B 122B 1,522B 122B 119B 5,259B |
| Net income | -3.39B -2.96B -2.74B -2.52B -4.76B -327B -4.85B -32.68B -12.82B -159B -12.73B -12.45B -550B | 9.76B 8.53B 7.89B 7.24B 13.7B 940B 13.95B 94.07B 36.9B 459B 36.65B 35.85B 1,584B |
| Net Debt | 9.46B 8.27B 7.65B 7.02B 13.28B 911B 13.52B 91.17B 35.76B 444B 35.52B 34.75B 1,536B | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-16 | $136.30 | +3.49% | 7,624,242 |
| 26-07-15 | $131.70 | +1.28% | 4,467,637 |
| 26-07-14 | $130.04 | -1.04% | 5,255,960 |
| 26-07-13 | $131.40 | +1.21% | 5,131,594 |
| 26-07-10 | $129.83 | -3.72% | 5,935,997 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
